NOT FOR DISTRIBUTION
Header cover image

Market Cap

US$644.8m

Last Updated

2021/04/15 23:14 UTC

Data Sources

Company Financials +

Executive Summary

PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. More Details


Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.


Similar Companies

Share Price & News

How has PetMed Express's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: PETS is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 15% a week.

Volatility Over Time: PETS's weekly volatility has increased from 10% to 15% over the past year.


Market Performance


7 Day Return

-2.2%

PETS

2.0%

US Online Retail

1.6%

US Market


1 Year Return

-0.4%

PETS

41.3%

US Online Retail

57.5%

US Market

Return vs Industry: PETS underperformed the US Online Retail industry which returned 46.4% over the past year.

Return vs Market: PETS underperformed the US Market which returned 56.6% over the past year.


Shareholder returns

PETSIndustryMarket
7 Day-2.2%2.0%1.6%
30 Day-8.1%4.4%3.4%
90 Day-7.3%2.7%8.6%
1 Year3.1%-0.4%41.5%41.3%60.3%57.5%
3 Year0.7%-10.7%81.9%81.7%62.6%51.9%
5 Year114.5%79.2%297.2%296.4%119.9%95.3%

Long-Term Price Volatility Vs. Market

How volatile is PetMed Express's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is PetMed Express undervalued compared to its fair value and its price relative to the market?

14.9%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: PETS ($32.47) is trading below our estimate of fair value ($37.78)

Significantly Below Fair Value: PETS is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: PETS is good value based on its PE Ratio (21.1x) compared to the US Online Retail industry average (34.8x).

PE vs Market: PETS is good value based on its PE Ratio (21.1x) compared to the US market (22.3x).


Price to Earnings Growth Ratio

PEG Ratio: PETS is poor value based on its PEG Ratio (1.8x)


Price to Book Ratio

PB vs Industry: PETS is good value based on its PB Ratio (4.7x) compared to the US Online Retail industry average (5.4x).


Future Growth

How is PetMed Express forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

11.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: PETS's forecast earnings growth (11.5% per year) is above the savings rate (2%).

Earnings vs Market: PETS's earnings (11.5% per year) are forecast to grow slower than the US market (18.4% per year).

High Growth Earnings: PETS's earnings are forecast to grow, but not significantly.

Revenue vs Market: PETS's revenue (3.4% per year) is forecast to grow slower than the US market (9.9% per year).

High Growth Revenue: PETS's revenue (3.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: PETS's Return on Equity is forecast to be high in 3 years time (23.6%)


Past Performance

How has PetMed Express performed over the past 5 years?

6.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: PETS has high quality earnings.

Growing Profit Margin: PETS's current net profit margins (9.9%) are higher than last year (9.3%).


Past Earnings Growth Analysis

Earnings Trend: PETS's earnings have grown by 6.5% per year over the past 5 years.

Accelerating Growth: PETS's earnings growth over the past year (20.9%) exceeds its 5-year average (6.5% per year).

Earnings vs Industry: PETS earnings growth over the past year (20.9%) underperformed the Online Retail industry 66.3%.


Return on Equity

High ROE: PETS's Return on Equity (22.1%) is considered high.


Financial Health

How is PetMed Express's financial position?


Financial Position Analysis

Short Term Liabilities: PETS's short term assets ($141.0M) exceed its short term liabilities ($26.9M).

Long Term Liabilities: PETS's short term assets ($141.0M) exceed its long term liabilities ($1.3M).


Debt to Equity History and Analysis

Debt Level: PETS is debt free.

Reducing Debt: PETS has not had any debt for past 5 years.

Debt Coverage: PETS has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: PETS has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is PetMed Express's current dividend yield, its reliability and sustainability?

3.48%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: PETS's dividend (3.45%) is higher than the bottom 25% of dividend payers in the US market (1.24%).

High Dividend: PETS's dividend (3.45%) is low compared to the top 25% of dividend payers in the US market (3.49%).


Stability and Growth of Payments

Stable Dividend: PETS's dividends per share have been stable in the past 10 years.

Growing Dividend: PETS's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (72.2%), PETS's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: PETS's dividends in 3 years are forecast to be covered by earnings (78% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

17.7yrs

Average board tenure


CEO

Menderes Akdag (59 yo)

20.08yrs

Tenure

US$1,303,460

Compensation

Mr. Menderes Akdag has been the Chief Executive Officer of PetMed Express, Inc. since March 16, 2001 and has been its President since August 2005. Mr. Akdag has a breadth of experience in the areas of dire...


CEO Compensation Analysis

Compensation vs Market: Menderes's total compensation ($USD1.30M) is below average for companies of similar size in the US market ($USD2.17M).

Compensation vs Earnings: Menderes's compensation has increased by more than 20% in the past year.


Board Members

Experienced Board: PETS's board of directors are seasoned and experienced ( 17.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: PETS insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

PetMed Express, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: PetMed Express, Inc.
  • Ticker: PETS
  • Exchange: NasdaqGS
  • Founded: 1996
  • Industry: Internet and Direct Marketing Retail
  • Sector: Retail
  • Market Cap: US$644.806m
  • Shares outstanding: 20.09m
  • Website: https://www.1800petmeds.com

Number of Employees


Location

  • PetMed Express, Inc.
  • 420 South Congress Avenue
  • Delray Beach
  • Florida
  • 33445
  • United States

Listings


Biography

PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/15 23:14
End of Day Share Price2021/04/15 00:00
Earnings2020/12/31
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.